The role of the canonical nf-κb signaling pathway in the development of acute liver failure

As a clinical emergency with a high mortality rate, the treatment of acute liver failure has been paid attention to by society. At present, liver transplantation is the most effective treatment for acute liver failure, but there is still an insufficient supply of liver sources and a poor prognosis. In view of the current therapeutic development of this disease, more researchers have turned their attention to the research of drugs related to the NF-kappa B pathway. The NF-kappa B canonical pathway has been proven to play a role in a variety of diseases, regulating inflammation, apoptosis, and other physiological processes. More and more evidence shows that the NF-kappa B canonical pathway regulates the pathogenesis of acute liver failure. In this review, we will summarize the regulation process of the NF-kappa B canonical pathway on acute liver failure, and develop a new way to treat acute liver failure by targeting the components of the pathway.